AXIM BIOTECHNOLOGIES, INC. (AXIM) Capital expenditures 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2023 · since FY2014: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $8,710 | -78.5% |
| FY2021 | $40,495 | -58.4% |
| FY2020 | $97,324 | — |
| FY2016 | $0 | -100.0% |
| FY2015 | $16,780 | — |
| FY2014 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice